Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Astrazeneca (0A4J)

Astrazeneca Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0A4J
DateTimeSourceHeadlineSymbolCompany
02/01/202415:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
27/12/202307:00UK RegulatoryAstraZeneca PLC AstraZeneca acquires GracellLSE:0A4JAstrazeneca Plc
22/12/202307:00UK RegulatoryAstraZeneca PLC Wainua (eplontersen) granted first US FDA approvalLSE:0A4JAstrazeneca Plc
14/12/202315:00UK RegulatoryAstraZeneca PLC Director/PDMR ShareholdingLSE:0A4JAstrazeneca Plc
12/12/202307:05UK RegulatoryAstraZeneca PLC AstraZeneca to acquire IcosavaxLSE:0A4JAstrazeneca Plc
01/12/202315:05UK RegulatoryAstraZeneca PLC Block listing Interim ReviewLSE:0A4JAstrazeneca Plc
01/12/202315:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
01/12/202307:00UK RegulatoryAstraZeneca PLC Discontinuation of two CRYSTALIZE evidence trialsLSE:0A4JAstrazeneca Plc
23/11/202315:00UK RegulatoryAstraZeneca PLC Director/PDMR ShareholdingLSE:0A4JAstrazeneca Plc
17/11/202307:00UK RegulatoryAstraZeneca PLC Truqap approved in US for HR+ breast cancerLSE:0A4JAstrazeneca Plc
14/11/202307:05UK RegulatoryAstraZeneca PLC Update on PACIFIC-2 Phase III trial for ImfinziLSE:0A4JAstrazeneca Plc
09/11/202315:00UK RegulatoryAstraZeneca PLC Director DeclarationLSE:0A4JAstrazeneca Plc
09/11/202307:10UK RegulatoryAstraZeneca PLC Imfinzi combination improves PFS in liver cancerLSE:0A4JAstrazeneca Plc
09/11/202307:05UK RegulatoryAstraZeneca PLC Agreement with Eccogene for clinical stage GLP-1RALSE:0A4JAstrazeneca Plc
09/11/202307:00UK RegulatoryAstraZeneca PLC 9M and Q3 2023 resultsLSE:0A4JAstrazeneca Plc
01/11/202315:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
01/11/202307:00UK RegulatoryAstraZeneca PLC AstraZeneca cell & gene therapy deal w/ CellectisLSE:0A4JAstrazeneca Plc
03/10/202307:00UK RegulatoryAstraZeneca PLC AstraZeneca settles Nexium liability litigationsLSE:0A4JAstrazeneca Plc
02/10/202315:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
22/09/202307:00UK RegulatoryAstraZeneca PLC Dato-DXd improved PFS in breast cancerLSE:0A4JAstrazeneca Plc
20/09/202307:00UK RegulatoryAstraZeneca PLC Alexion completes Pfizer gene therapy agreementLSE:0A4JAstrazeneca Plc
15/09/202315:00UK RegulatoryAstraZeneca PLC Enhertu recommended in EU for HER2-mutant NSCLCLSE:0A4JAstrazeneca Plc
11/09/202316:00UK RegulatoryAstraZeneca PLC Fasenra Phase III EGPA trial met primary endpointLSE:0A4JAstrazeneca Plc
06/09/202307:00UK RegulatoryAstraZeneca PLC Update on US review of Ultomiris for NMOSDLSE:0A4JAstrazeneca Plc
01/09/202315:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
01/08/202315:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
28/07/202307:05UK RegulatoryAstraZeneca PLC Alexion enters gene therapy agreement with PfizerLSE:0A4JAstrazeneca Plc
28/07/202307:00UK RegulatoryAstraZeneca PLC Half-year ReportLSE:0A4JAstrazeneca Plc
17/07/202318:10UK RegulatoryAstraZeneca PLC Beyfortus approved in US for infant RSV preventionLSE:0A4JAstrazeneca Plc
03/07/202315:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:0A4J